These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27268592)

  • 1. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
    El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
    Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
    Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
    Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
    J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
    Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
    Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia.
    Ouyang W; Li X; Wan Q; Ye Q
    Hepatogastroenterology; 2015; 62(138):346-9. PubMed ID: 25916061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESKAPE pathogens in pediatric cardiac surgery patients: 5-year microbiological monitoring in a tertiary hospital in Kazakhstan.
    Baigenzhin A; Bissenova N; Yergaliyeva A; Marassulov S; Tuleubayeva E; Aitysheva U
    Acta Microbiol Immunol Hung; 2024 Sep; 71(3):211-219. PubMed ID: 39190489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
    Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
    Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiology and prevalence of E
    de la Cruz-Hernández I; Cornejo-Juárez P; Tellez-Miranda O; Barrera-Pérez L; Sandoval-Hernández S; Vilar-Compte D; Velázquez-Acosta C; Volkow P
    Am J Infect Control; 2020 Jan; 48(1):40-45. PubMed ID: 31395288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
    Bodro M; Gudiol C; Garcia-Vidal C; Tubau F; Contra A; Boix L; Domingo-Domenech E; Calvo M; Carratalà J
    Support Care Cancer; 2014 Mar; 22(3):603-10. PubMed ID: 24170166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.
    Ragupathi NKD; Bakthavatchalam YD; Mathur P; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
    Indian J Med Res; 2019 Feb; 149(2):222-231. PubMed ID: 31219087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19.
    Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM
    J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
    Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
    S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the main MDR pathogens: prevalence and treatment options.
    Esposito S; De Simone G
    Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.
    Čivljak R; Giannella M; Di Bella S; Petrosillo N
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):249-64. PubMed ID: 24392752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India.
    Kharat AS; Makwana N; Nasser M; Gayen S; Yadav B; Kumar D; Veeraraghavan B; Mercier C
    Int J Antimicrob Agents; 2024 May; 63(5):107125. PubMed ID: 38431109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
    De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
    J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.